The main limitation of this study is that it did not test the possibility that NF-κB inhibition may ameliorate the progression of established kidney disease, although it should be noted that this would be a difficult task considering the high mortality observed in aging rats with DKD. The gene discussed is NFKB1; the disease is diabetic kidney disease.